Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Absci Corporation Common Stock
ABSI | US
6.35
USD-0.17
-2.61%
ABSI | US
About Absci Corporation Common Stock
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
02/06/2026
Close
6.35
Open
6.42
High
6.55
Low
6.13
Absci Corporation operates as a generative AI drug creation company in the United States. Its integrated drug creation platform identifies novel drug targets and creates biotherapeutic candidates. The company was founded in 2011 and is headquartered in Vancouver Washington.
View LessABSI | US
Risk
108.4
Sharpe
1.44
Luna's Score
51/100
Recommendation
Hold
Luna says (ABSI | US)
What's Working
Positive Momentum
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Sharpe Ratio (> 1.2)
What's not Working
High Short-term Volatility
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
High Short percentage (> 15%)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
117.8%1 month
108.4%3 months
104.7%6 months
94.8%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
2.12
Debt to equity
0.06
Debt to assets
0.05
Ent. to EBITDA
-0.39
Ent. to rev.
103.72
PEG
-
Other Fundamentals
EBITDA
-83.96M
MarketCap
721.08M
MarketCap(USD)
721.08M
Div. yield
-
Op. margin
-2.10K
Erngs. growth
-
Rev. growth
-62.30
Ret. on equity
-42.24
Short ratio
14.49
Short perc.
17.41
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
2.85
Range1M
2.85
Range3M
5.10
Volumes: Market Activity
Rel. volume
0.74
Price X volume
23.39M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.39 | - | Cheaper |
| Ent. to Revenue | 103.72 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 2.12 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 104.66 | - | Riskier |
| Debt to Equity | 0.06 | -1.23 | Expensive |
| Debt to Assets | 0.05 | 0.25 | Cheaper |
| Market Cap | 721.08M | - | Emerging |
